EUVIMEDEUVIMED entdecken
Crossref

Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data

Nana Komatsu, Takashi Chishima, Chie Watanabe, Kanae Taruno, Mayuko Inuzuka, Masanori Oshi, Masami Arai, Seigo Nakamura

Breast Cancer Research and Treatment · 2025

DOI: 10.1007/s10549-024-07485-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Nana Komatsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Showa University Northern Yokohama Hospital, 35-1 Chigasaki-Chuo, Tsuduki, Yokohama, Kanagawa, 224-8503, Japan. Hauptthemen laut MEDLINE: BRCA2 Protein, BRCA1 Protein, Hereditary Breast and Ovarian Cancer Syndrome, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: With the increasing demand for BRCA genetic testing, most existing prediction models were developed using data from individuals of European descent. This study aimed to identify clinicopathological factors of hereditary breast and ovarian cancer (HBOC) syndrome and develop the first Japanese-specific prediction model for BRCA pathogenic variant carriers in Japan. METHODS: We utilized data from 3072 Japanese patients with breast cancer aggregated by the Japanese Organization of Hereditary Breast and Ovarian Cancer registry. Prediction models were developed using 70% of the overall dataset and validated using the remaining 30%. Factors associated with the BRCA pathogenic variant status were identified using logistic univariate analysis, and significant factors were further analyzed using logistic multivariate analysis to develop prediction models for BRCA1/2 (BRCA1 and/or BRCA2), BRCA1, and BRCA2 pathogenic variants. RESULTS: BRCA1 showed associations with aggressive clinicopathological factors such as triple-negative breast cancer and nuclear grade 3. Moreover, the prediction model showed a high area under the curve (AUC) of 0.879. By contrast, BRCA2 exhibited fewer characteristic associated factors, and the AUC of the model was 0.669. Common factors shared by BRCA1/2, BRCA1, and BRCA2 were the age at diagnosis of breast cancer and the youngest age of relatives with breast cancer. Consistent with previous research, early-onset breast cancer appeared to be strongly associated with HBOC. CONCLUSION: We successfully developed prediction models for BRCA1/2, BRCA1, and BRCA2 pathogenic variants. By accurately stratifying patients' risk and guiding targeted screening and preventative interventions, these models will contribute to improved management and outcomes of HBOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinBRCA1 ProteinHereditary Breast and Ovarian Cancer SyndromeBreast NeoplasmsHumansFemaleMiddle AgedJapanRegistriesAdultGenetic Predisposition to DiseaseAgedGenetic TestingHeterozygoteMutationEast Asian People

Stichwörter der Autor:innen

BRCA genetic testingBreast cancerHereditary breast and ovarian cancer syndromePrediction model

Substanzen

BRCA2 ProteinBRCA1 ProteinBRCA2 protein, humanBRCA1 protein, human

Autor:innen und Institutionen

  • Department of Breast Surgery, Showa University Northern Yokohama Hospital, 35-1 Chigasaki-Chuo, Tsuduki, Yokohama, Kanagawa, 224-8503, Japan.
  • Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Department of Breast Surgery, Showa University Northern Yokohama Hospital, 35-1 Chigasaki-Chuo, Tsuduki, Yokohama, Kanagawa, 224-8503, Japan. chishima-t@med.showa-u.ac.jp.
  • Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Shinagawa, Tokyo, Japan. chishima-t@med.showa-u.ac.jp.
  • School of Nursing and Rehabilitation Sciences, Showa University, Shinagawa, Tokyo, Japan.
  • Department of Breast Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.

Zitieren

APA

Komatsu, N., Chishima, T., Watanabe, C., Taruno, K., Inuzuka, M., Oshi, M., Arai, M., & Nakamura, S. (2025). Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07485-6

Vancouver

Komatsu N, Chishima T, Watanabe C, Taruno K, Inuzuka M, Oshi M, et al. Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07485-6

BibTeX
@article{Komatsu2025,
  author = {Komatsu, Nana and Chishima, Takashi and Watanabe, Chie and Taruno, Kanae and Inuzuka, Mayuko and Oshi, Masanori and Arai, Masami and Nakamura, Seigo},
  title = {Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  doi = {10.1007/s10549-024-07485-6}
}
Kostenlos starten →